IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹249 Cr | ₹235 Cr | ₹119 Cr | ₹93 Cr | ₹70 Cr |
What is the latest Contingent Liabilities ratio of IPCA LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹249 Cr |
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹119 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹70 Cr |
How is Contingent Liabilities of IPCA LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹249 Cr | 6.10 | |
| Mar2025 | ₹235 Cr | 97.16 | |
| Mar2024 | ₹119 Cr | 27.48 | |
| Mar2023 | ₹93 Cr | 34.12 | |
| Mar2022 | ₹70 Cr | - | |
Compare Contingent Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹46,509.6 Cr | -5.4% | -0.2% | 39.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -5.4% |
-0.2% |
39.1% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses